AI Article Synopsis
- Recent advancements in genetic diagnosis have improved our understanding of chronic mucocutaneous candidiasis (CMC) and its underlying causes.
- The review discusses recent insights into how CMC develops, effective diagnostic methods, and new management approaches.
- Overall, these developments may lead to better treatment options for individuals suffering from CMC.
Article Abstract
Recent progress in the methods of genetic diagnosis of inborn errors of immunity has contributed to a better understanding of the pathogenesis of chronic mucocutaneous candidiasis (CMC) and potential therapeutic options. This review describes the latest advances in the understanding of the pathophysiology, diagnostic strategies, and management of chronic mucocutaneous candidiasis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11191067 | PMC |
| http://dx.doi.org/10.1097/INF.0000000000004321 | DOI Listing |
Publication Analysis
Top Keywords
mucocutaneous candidiasis
12
chronic mucocutaneous
8
candidiasis insights
4
insights diagnosis
4
diagnosis treatment
4
treatment progress
4
progress methods
4
methods genetic
4
genetic diagnosis
4
diagnosis inborn
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!